Terms ending in 2038
Every in-force patent on Cathay Biotech Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,485,986 | Cells and Methods for Production of Lysine and Lysine-Derived Products In force · High confidence | Cathay Biotech Inc. and Cibt America Inc. | In force | High confidence | |
| US 11,781,163 | Reducing the Accumulation of Imines/Enamines for the Production of Amino Acids or Amino Acid-Derived Products In force · High confidence | Cathay Biotech Inc. and Cibt America Inc., | In force | High confidence | |
| US 10,851,394 | Decanedioic Acid Produced by Microbial Fermentation Process and Preparation Method Thereof In force · High confidence | Cathay Biotech Inc. | In force | High confidence | |
| US 11,753,629 | Directed Evolution of CYP52A12 Gene and Its Use in Dicarboxylic Acid Production In force · High confidence | Cathay Biotech Inc. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.